Bed Bath & Beyond Shares Fall Following Q2 Earnings Miss, Restructuring Plans
Bed Bath & Beyond shares are trading lower after reporting second-quarter financial results that missed Wall Street expectations.
Stocks · News reference
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Gainers Bloomin Brands (NASDAQ:BLMN) shares moved upwards by 37.7% to $12.29 during Wednesday's regular session. The company's market cap stands at $763.6 million. As per the press release, Q2 earnings came out
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Bed Bath & Beyond shares are trading lower after the company reported worse-than-expected Q2 financial results and issued Q3 sales guidance below estimates. The company will eliminate non-performing assets and consolidate resources for cost savings.
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Gainers Bloomin Brands (NASDAQ:BLMN) stock moved upwards by 22.0% to $10.88 during Wednesday's pre-market session. The company's market cap stands at $763.6 million. The company's, Q2 earnings came out
Starboard Value LP Cuts Share Stake In Bloomin Brands By 47.6% To 4.2M Shares
-SEC Filing
Piper Sandler Maintains Neutral on Bloomin Brands, Raises Price Target to $12
Piper Sandler analyst Brian Mullan maintains Bloomin Brands (NASDAQ:BLMN) with a Neutral and raises the price target from $9 to $12.
Morgan Stanley Maintains Equal-Weight on Bloomin Brands, Raises Price Target to $12
Morgan Stanley analyst John Glass maintains Bloomin Brands (NASDAQ:BLMN) with a Equal-Weight and raises the price target from $8 to $12.